How has Talphera, Inc.'s increase (decrease) in accounts receivable changed year-over-year?

Talphera, Inc.'s increase (decrease) in accounts receivable decreased by 100.0% year-over-year, from $27K to -$0.

Talphera, Inc. TLPH Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

Baxter InternationalBAX

-$152M-485%

ZymeworksZYME

$36K+100%

Syndax PharmaceuticalsSNDX

——

Other financials

Income statement

See full

Revenue--100%

Gross profit-$1.9M-52.7%

Operating income-$3.9M-35.4%

Net income-$2.6M+1.4%

EPS (diluted)-$0.10+37.5%

Balance sheet

See full

Cash & equivalents$3.8M-29.0%

Total debt$3.4M-79.7%

Total equity$18.5M+230%

Total assets$30.2M+101%

Cash flow

See full

Operating cash flow-$3.4M+2.0%

CapEx-—

Free cash flow-$2.3M+42.9%

Valuation

See full

Market cap$53.46M+516%

P/S53,456.6×+53,135×

Profitability

See full

Gross margin-127.7%-136pp

Operating margin-1,451,600%-1,507,145pp

Net margin-1,425,300%-1,471,200pp

FCF margin-5,116.7%-6,779pp

Returns & leverage

See full

Return on equity-118.4%+15.4pp

Debt / equity0.2×—

Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Talphera, Inc.'s increase (decrease) in accounts receivable?: Talphera, Inc. (TLPH) reported increase (decrease) in accounts receivable of -$0 in Q1 2026.
How has Talphera, Inc.'s increase (decrease) in accounts receivable changed year-over-year?: Talphera, Inc.'s increase (decrease) in accounts receivable decreased by 100.0% year-over-year, from $27K to -$0.